The Future of Clinical Trials and Pharmacovigilance
4 years ago
By Josh Neil
This year, Proventa debuted its successful online event format for the first time, providing experts from across the sector with an online forum just as useful and educational as our physical events have always been. During the recent Clinical Trials/Pharmacovigilance events, held on 25 June, delegates received the chance to not only discover new insights in their chosen profession but also make important connections and engage with peers through the interactive roundtable discussions and panel debates.
After the event, several facilitators relayed what they thought the main obstacles and themes of the next five years will be. These ranged from the problem of COVID-19 and safety, to how AI will change clinical trials and pharmacovigilance over the coming years.
If you’re unable to see the below PDF, click here.
For more information on future events, including the upcoming Clinical Operations, CTSC and Pharmacovigilance meetings in November 2020, click here.
Joshua Neil, Editor
Proventa International
Future Trends in Clinical Trials and Pharmacovigilance for the Next 5 Years
The field of clinical trials and pharmacovigilance (PV) is constantly evolving, driven by advances in medical science, technology, and regulatory requirements. As we look ahead to the next five years, it is evident that significant changes and innovations will shape...
9 months agoFuture Trends in Clinical Trials and Pharmacovigilance for the Next 5 Years
The field of clinical trials and pharmacovigilance (PV) is constantly evolving, driven by advances in medical science, technology, and regulatory requirements. As we look ahead to the next five years, it is evident that significant changes and innovations will shape...
9 months ago
How to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency
Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...
1 year agoHow to Reduce the Cost of Clinical Trial Supply Chain While Maintaining Quality and Efficiency
Clinical trial supply chain is a critical component of drug development, ensuring that drugs are available for testing, regulatory approval, and distribution. However, managing this supply chain can be challenging, with factors such as cost, quality, and efficiency all coming...
1 year ago
Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
3 years agoRaising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
3 years ago